drugset / Trial / NCT06394713
A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
This study is designed to evaluate the safety and efficacy of QLF31907 combination therapy in advanced malignant tumors.
Timeline
- Start
- 2024-06-15
- Primary completion
- 2025-06-15
- Completion
- 2026-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 75 mg/m2 | Intravenous |
| Subject | Irinotecan | Small molecule | 125 mg/m2 | Intravenous |
| Subject | QLF31907 | Unknown | — | Intravenous |